Avidity Partners Management as of March 31, 2025
Portfolio Holdings for Avidity Partners Management
Avidity Partners Management holds 64 positions in its portfolio as reported in the March 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Humana (HUM) | 8.1 | $43M | 161k | 264.60 | |
| Boston Scientific Corporation (BSX) | 6.5 | $34M | 336k | 100.88 | |
| Dianthus Therapeutics (DNTH) | 5.9 | $31M | 1.7M | 18.14 | |
| UnitedHealth (UNH) | 5.0 | $26M | 51k | 523.75 | |
| Cg Oncology (CGON) | 4.6 | $24M | 981k | 24.49 | |
| Natera (NTRA) | 3.2 | $17M | 119k | 141.41 | |
| Syndax Pharmaceuticals (SNDX) | 3.1 | $16M | 1.3M | 12.29 | |
| Regeneron Pharmaceuticals (REGN) | 3.1 | $16M | 25k | 634.23 | |
| EXACT Sciences Corporation (EXAS) | 2.9 | $15M | 353k | 43.29 | |
| Beam Therapeutics (BEAM) | 2.6 | $14M | 710k | 19.53 | |
| Glaukos (GKOS) | 2.5 | $13M | 134k | 98.42 | |
| Dex (DXCM) | 2.3 | $12M | 180k | 68.29 | |
| Ultragenyx Pharmaceutical (RARE) | 2.2 | $12M | 322k | 36.21 | |
| AmerisourceBergen (COR) | 2.1 | $11M | 39k | 278.09 | |
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 1.9 | $9.9M | 80k | 124.15 | |
| Tenet Healthcare Corp Com New (THC) | 1.8 | $9.7M | 72k | 134.50 | |
| Neurocrine Biosciences (NBIX) | 1.8 | $9.5M | 86k | 110.60 | |
| Danaher Corporation (DHR) | 1.7 | $9.1M | 45k | 205.00 | |
| Axsome Therapeutics (AXSM) | 1.7 | $9.0M | 77k | 116.63 | |
| Genmab A/s Sponsored Ads Call Option (GMAB) | 1.6 | $8.5M | 433k | 19.58 | |
| Arvinas Ord (ARVN) | 1.6 | $8.2M | 1.2M | 7.02 | |
| Insmed Com Par $.01 (INSM) | 1.6 | $8.2M | 107k | 76.29 | |
| Organon & Co Common Stock (OGN) | 1.5 | $8.0M | 535k | 14.89 | |
| Thermo Fisher Scientific (TMO) | 1.5 | $7.7M | 16k | 497.60 | |
| Xenon Pharmaceuticals (XENE) | 1.5 | $7.7M | 229k | 33.55 | |
| Spdr Ser Tr S&p Biotech (XBI) | 1.5 | $7.6M | 94k | 81.10 | |
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 1.4 | $7.6M | 529k | 14.38 | |
| Revolution Medicines (RVMD) | 1.4 | $7.5M | 213k | 35.36 | |
| Teva Pharmaceutical Inds Sponsored Ads (TEVA) | 1.4 | $7.4M | 481k | 15.37 | |
| Avantor (AVTR) | 1.4 | $7.3M | 453k | 16.21 | |
| Ideaya Biosciences (IDYA) | 1.4 | $7.3M | 445k | 16.38 | |
| Doximity Cl A (DOCS) | 1.4 | $7.1M | 123k | 58.03 | |
| Janux Therapeutics (JANX) | 1.3 | $7.0M | 258k | 27.00 | |
| Healthequity (HQY) | 1.3 | $6.9M | 78k | 88.37 | |
| Blueprint Medicines (BPMC) | 1.2 | $6.1M | 69k | 88.51 | |
| United Therapeutics Corporation (UTHR) | 1.0 | $5.2M | 17k | 308.27 | |
| Phathom Pharmaceuticals (PHAT) | 1.0 | $5.0M | 800k | 6.27 | |
| Immunic (IMUX) | 0.9 | $4.9M | 4.5M | 1.09 | |
| Bruker Corporation (BRKR) | 0.9 | $4.8M | 115k | 41.74 | |
| Perspective Therapeutics Com New (CATX) | 0.9 | $4.7M | 2.2M | 2.13 | |
| Context Therapeutics (CNTX) | 0.9 | $4.6M | 7.5M | 0.61 | |
| Oruka Therapeutics (ORKA) | 0.7 | $3.6M | 352k | 10.26 | |
| Uniqure Nv SHS (QURE) | 0.7 | $3.6M | 336k | 10.60 | |
| Biohaven (BHVN) | 0.7 | $3.5M | 145k | 24.04 | |
| ACADIA Pharmaceuticals (ACAD) | 0.5 | $2.8M | 169k | 16.61 | |
| Royalty Pharma Shs Class A (RPRX) | 0.5 | $2.7M | 87k | 31.13 | |
| Bridgebio Pharma (BBIO) | 0.5 | $2.6M | 75k | 34.57 | |
| Kezar Life Sciences Com New (KZR) | 0.5 | $2.5M | 503k | 4.88 | |
| Akero Therapeutics (AKRO) | 0.4 | $2.3M | 57k | 40.48 | |
| Soleno Therapeutics (SLNO) | 0.4 | $2.3M | 32k | 71.45 | |
| Capricor Therapeutics Com New (CAPR) | 0.4 | $2.3M | 239k | 9.49 | |
| Lexeo Therapeutics (LXEO) | 0.4 | $2.2M | 645k | 3.47 | |
| Vera Therapeutics Cl A (VERA) | 0.4 | $2.2M | 91k | 24.02 | |
| Regenxbio Inc equity us cm (RGNX) | 0.4 | $1.9M | 260k | 7.15 | |
| Ionis Pharmaceuticals (IONS) | 0.3 | $1.8M | 60k | 30.17 | |
| Mirum Pharmaceuticals (MIRM) | 0.3 | $1.8M | 40k | 45.05 | |
| Newamsterdam Pharma Company Ordinary Shares (NAMS) | 0.3 | $1.4M | 68k | 20.47 | |
| Agilon Health (AGL) | 0.3 | $1.3M | 305k | 4.33 | |
| Scynexis Com New (SCYX) | 0.2 | $1.2M | 1.2M | 0.95 | |
| Vaxcyte (PCVX) | 0.2 | $869k | 23k | 37.76 | |
| Karyopharm Therapeutics Com New (KPTI) | 0.1 | $503k | 135k | 3.74 | |
| Enliven Therapeutics (ELVN) | 0.0 | $222k | 11k | 19.68 | |
| Hyperfine Com Cl A (HYPR) | 0.0 | $159k | 222k | 0.72 | |
| Reviva Pharmaceutcls Hldgs I (RVPH) | 0.0 | $132k | 138k | 0.95 |